Author:
Linxweiler Johannes,Körbel Christina,Müller Andreas,Jüngel Eva,Blaheta Roman,Heinzelmann Joana,Stöckle Michael,Junker Kerstin,Menger Michael D.,Saar Matthias
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Grisanzio, C. et al. Orthotopic xenografts of RCC retain histological, immunophenothypic and genetic features of tumours in patients. J Pathol. 225, 212–21 (2011).
2. Thong, A. E. et al. Tissue slice grafts of human renal cell carcinoma: an authentic preclinical model with high engraftment rate and metastatic potential. Urol Oncol. 32(43), e23–30 (2014).
3. Ingels, A. et al. Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal cell carcinoma tumorgrafts. Int J Cancer. 134, 2322–9 (2014).
4. Fidler, I. J., Naito, S. & Pathak, S. Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice. Cancer Metastasis Rev. 9, 149–65 (1990).
5. Manzotti, C., Audisio, R. A. & Pratesi, G. Importance of orthotopic implantation for human tumors as model systems: Relevance to metastasis and invasion. Clin Exp Metastasis. 11, 5–14 (1993).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献